High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours - PubMed (original) (raw)
. 2008 Dec 1;416(2):153-9.
doi: 10.1042/bj20081834.
Affiliations
- PMID: 18990089
- DOI: 10.1042/bj20081834
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours
Helena Carén et al. Biochem J. 2008.
Abstract
ALK (anaplastic lymphoma kinase) is oncogenic in several tumours and has recently been identified as a predisposition gene for familial NB (neuroblastoma) harbouring mutations in the TKD (tyrosine kinase domain). We have analysed a large set of sporadic human NB primary tumours of all clinical stages for chromosomal re-arrangements using a CGH (comparative genomic hybridization) array (n=108) and mutations of the ALK gene (n=90), and expression of ALK and related genes (n=19). ALK amplification or in-gene re-arrangements were found in 5% of NB tumours and mutations were found in 11%, including two novel not previously published mutations in the TKD, c.3733T>A and c.3735C>A. DNA mutations in the TKD and gene amplifications were only found in advanced large primary tumours or metastatic tumours, and correlated with the expression levels of ALK and downstream genes as well as other unfavourable features, and poor outcome. The results of the present study support that the ALK protein contributes to NB oncogenesis providing a highly interesting putative therapeutic target in a subset of unfavourable NB tumours.
Similar articles
- Oncogenic mutations of ALK kinase in neuroblastoma.
Chen Y, Takita J, Choi YL, Kato M, Ohira M, Sanada M, Wang L, Soda M, Kikuchi A, Igarashi T, Nakagawara A, Hayashi Y, Mano H, Ogawa S. Chen Y, et al. Nature. 2008 Oct 16;455(7215):971-4. doi: 10.1038/nature07399. Nature. 2008. PMID: 18923524 - Copy number status and mutation analyses of anaplastic lymphoma kinase (ALK) gene in 90 sporadic neuroblastoma tumors.
Bagci O, Tumer S, Olgun N, Altungoz O. Bagci O, et al. Cancer Lett. 2012 Apr 1;317(1):72-7. doi: 10.1016/j.canlet.2011.11.013. Epub 2011 Nov 13. Cancer Lett. 2012. PMID: 22085494 - Oncogenic anaplastic lymphoma kinase (ALK) mutation in neuroblastomas and other pediatric tumors.
Kwon MJ, Choi YL, Sung KW, Kang SY, Park SM, Choi SY, Kim JS, Suh YL. Kwon MJ, et al. Pathol Res Pract. 2011 Oct 15;207(10):634-9. doi: 10.1016/j.prp.2011.07.011. Epub 2011 Sep 21. Pathol Res Pract. 2011. PMID: 21940108 - Oncogenic mutations of ALK in neuroblastoma.
Ogawa S, Takita J, Sanada M, Hayashi Y. Ogawa S, et al. Cancer Sci. 2011 Feb;102(2):302-8. doi: 10.1111/j.1349-7006.2010.01825.x. Cancer Sci. 2011. PMID: 21205076 Free PMC article. Review. - The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene.
Kelleher FC, McDermott R. Kelleher FC, et al. Eur J Cancer. 2010 Sep;46(13):2357-68. doi: 10.1016/j.ejca.2010.04.006. Epub 2010 May 5. Eur J Cancer. 2010. PMID: 20451371 Review.
Cited by
- Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement.
Suman M, Löfgren M, Fransson S, Yousuf JI, Svensson J, Djos A, Martinsson T, Kogner P, Kling T, Carén H. Suman M, et al. J Transl Med. 2024 Aug 31;22(1):808. doi: 10.1186/s12967-024-05634-5. J Transl Med. 2024. PMID: 39217334 Free PMC article. - Anaplastic Lymphoma Kinase signaling stabilizes SLC3A2 expression via MARCH11 to promote neuroblastoma cell growth.
Lai WY, Chuang TP, Borenäs M, Lind DE, Hallberg B, Palmer RH. Lai WY, et al. Cell Death Differ. 2024 Jul;31(7):910-923. doi: 10.1038/s41418-024-01319-0. Epub 2024 Jun 10. Cell Death Differ. 2024. PMID: 38858548 Free PMC article. - Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular targets for precision interventions.
Zheng M, Kumar A, Sharma V, Behl T, Sehgal A, Wal P, Shinde NV, Kawaduji BS, Kapoor A, Anwer MK, Gulati M, Shen B, Singla RK, Bungau SG. Zheng M, et al. Front Cell Dev Biol. 2024 Mar 27;12:1353860. doi: 10.3389/fcell.2024.1353860. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38601081 Free PMC article. Review. - Anaplastic Lymphoma Kinase (ALK) in Posterior Cranial Fossa Tumors: A Scoping Review of Diagnostic, Prognostic, and Therapeutic Perspectives.
Mousa DV, Mavrovounis G, Argyropoulos D, Stranjalis G, Kalamatianos T. Mousa DV, et al. Cancers (Basel). 2024 Feb 2;16(3):650. doi: 10.3390/cancers16030650. Cancers (Basel). 2024. PMID: 38339401 Free PMC article. Review. - Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors.
Zhu K, Xia Y, Tian X, He Y, Zhou J, Han R, Guo H, Song T, Chen L, Tian X. Zhu K, et al. Front Genet. 2023 Sep 8;14:1271381. doi: 10.3389/fgene.2023.1271381. eCollection 2023. Front Genet. 2023. PMID: 37745860 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical